文献速递肺外科

局限期小细胞肺癌手术切除范围对结局的影响

The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-03-22

该研究利用美国国家癌症数据库分析局限期小细胞肺癌(SCLC)患者接受楔形切除、肺段切除与肺叶切除的结局。共纳入1948例cT1-2N0M0患者,楔形切除者生存劣于肺叶切除,肺段切除与肺叶切除生存相似。

要点

  • 楔形切除与较差的总体生存相关(HR 1.53,95%CI 1.31-1.79)。
  • 肺段切除与肺叶切除的生存相似(HR 1.20,95%CI 0.87-1.67)。
  • 楔形切除与更高的切缘阳性(>R0)风险相关。

核心结论

  • 局限期SCLC患者接受楔形切除较肺叶切除生存更差,而肺段切除与肺叶切除生存相似。

研究设计与样本

  • 回顾性队列研究,利用美国国家癌症数据库纳入2004-2015年cT1-2N0M0期接受根治性手术的SCLC患者1948例。

主要发现

  • 楔形切除619例(32%),肺段切除96例(5%),肺叶切除1233例(63%)。
  • 未调整5年OS:楔形切除31%(95%CI 27-35),肺段切除35%(95%CI 25-49),肺叶切除45%(95%CI 42-49)。
  • 多变量Cox模型显示楔形切除OS劣于肺叶切除(HR 1.53,95%CI 1.31-1.79),肺段切除与肺叶切除相似(HR 1.20,95%CI 0.87-1.67)。
  • 倾向评分匹配多变量分析中肺段切除与肺叶切除生存仍相似。
  • 楔形切除较肺叶切除有更高的>R0切除风险。

临床怎么用

  • 对于局限期SCLC,肺叶切除应作为首选解剖性切除方式。
  • 楔形切除可能带来更差生存和更高切缘阳性风险,应谨慎选择。
  • 肺段切除在特定患者中可作为肺叶切除的替代选择。

局限性

  • 回顾性数据库研究,存在选择偏倚,如肺叶切除患者更年轻、合并症更少且更多有私人保险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is poor understanding of the comparative effectiveness of lobar and sublobar resections for limited-stage small cell lung cancer (SCLC). We analyzed the National Cancer Database to examine the outcomes of patients undergoing wedge resection (WR), segmentectomy (SR), and lobectomy (LB) for limited-stage SCLC. METHODS: Patients with cT1-2N0M0 SCLC (2004-2015) who underwent definitive surgery were identified and stratified by extent of resection: WR, SR, or LB. The primary outcome was overall survival (OS) and secondary outcomes were margin-positive resection (>R0) and pathologic nodal upstaging. RESULTS: A total 1948 patients met study criteria: 619 (32%) underwent WR, 96 (5%) SR, and 1233 (63%) LB. Patients receiving LB were more likely to be younger, have fewer comorbidities, and be privately insured. The unadjusted 5-year OS of WR, SR, and LB patients was 31% (95% confidence interval [CI], 27-35), 35% (95% CI, 25-49), and 45% (95% CI, 42-49), respectively. In a multivariable Cox model, WR was associated with worse OS (hazard ratio, 1.53; 95% CI, 1.31-1.79) and SR similar OS (hazard ratio, 1.20; 95% CI, 0.87-1.67) compared with LB. SR was associated with similar survival compared with LB in a propensity score-matched multivariable analysis as well. WR was also associated with greater odds of >R0 resection compared with LB. CONCLUSIONS: In this study, patients with limited-stage SCLC undergoing WR experienced worse survival compared with those undergoing LB; survival was similar between segmentectomy and LB.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Raman V, Jawitz OK, Yang CJ, et al. The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. J Thorac Cardiovasc Surg. 2020. PMID: 32327184. doi:10.1016/j.jtcvs.2020.02.135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。